alpha-c-Met/EGFR-0286 bispecific antibody drug conjugate (Sorrento Therapeutics)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2025/03/18 18:07:52

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐalpha-c-Met/EGFR-0286 bispecific antibody drug conjugate (Sorrento Therapeutics)
่ฏ็‰ฉๅˆซ็งฐN/A
่ฏ็‰ฉ็ฑปๅž‹็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๆŠ—ไฝ“็ผ€ๅˆ็‰ฉ > ๆŠ—ไฝ“ๅถ่”่ฏ็‰ฉ๏ผˆADC๏ผ‰็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ๅคš็‰นๅผ‚ๆ€งๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ๅŒ็‰นๅผ‚ๆ€งๆŠ—ไฝ“
ไฝœ็”จๆœบๅˆถ่กจ็šฎ็”Ÿ้•ฟๅ› ๅญๅ—ไฝ“erbB1ๆ‹ฎๆŠ—ๅ‰‚่‚็ป†่ƒž็”Ÿ้•ฟๅ› ๅญๅ—ไฝ“ๆŠ‘ๅˆถๅ‰‚
้ถ็‚น่‚็ป†่ƒž็”Ÿ้•ฟๅ› ๅญๅ—ไฝ“่กจ็šฎ็”Ÿ้•ฟๅ› ๅญๅ—ไฝ“erbB1
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡้žๅฐ็ป†่ƒž่‚บ็™Œ
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ไธดๅบŠๅ‰
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธSorrento Therapeutics Inc
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธSorrento Therapeutics Inc
้žๆดป่ทƒๅ…ฌๅธN/A
ๆดป่ทƒ้€‚ๅบ”็—‡้žๅฐ็ป†่ƒž่‚บ็™Œ
้žๆดป่ทƒ้€‚ๅบ”็—‡N/A

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A